Literature DB >> 23917391

Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis.

Raquel Almodóvar1, Valeria Ríos, Sara Ocaña, Milena Gobbo, María-Luisa Casas, Pedro Zarco-Montejo, Xavier Juanola.   

Abstract

To assess the association between biomarkers of inflammation, cartilage and bone turnover with gender, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Spondylitis Disease Activity Score (ASDAS) and bone marrow oedema in resonance magnetic imaging (MRI) of sacroiliac joints (SIJs) and radiological damage in early spondyloarthritis (SpA). Cross-sectional study of 60 patients (56.7 % females; mean age, 32.4 years) with early SpA. Sociodemographic data, clinical features, serum matrix metalloproteinase 3 (MMP-3), high sensitivity C-reactive protein (hsCRP), C-terminal cross-linking telopeptides of type I collagen (CTX-I) and urinary deoxypyridinoline, ASDAS, BASDAI, BASFI, BASRI and MRI of the SIJs were collected. The mean (SD) disease duration was 12.4 (6.8 months). Twenty-two (68.7 %) of the 32 patients had active sacroiliitis by MRI. MMP-3 and CTX I correlated with swollen joint (r = 0.515, r = 0.386, p = 0.01). hsCRP correlated with ESR (r = 0.303, p = 0.05), with CRP (r = 0.455, p = 0.01) and with total BASRI (r = 0.95, p = 0.05). Biomarkers were unrelated with the rest of variables. Levels of MMP-3 (44.3 ± 52.4 vs 24.7 ± 33.4, p < 0.05) and CTX-I (0.53 ± 0.45 vs 0.24 ± 0.38; p < 0.05) were higher in men. Our study shows that CTX-I and MMP-3 are a marker of peripheral disease activity in early SpA. Male gender had higher levels of CTX-I and MMP-3, which may indicate higher disease activity. Higher hsCRP levels trended towards correlation with more baseline radiographic damage. Therefore, these biomarkers may help identify a subgroup of patients who will need closer monitoring and more intensive treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23917391     DOI: 10.1007/s10067-013-2349-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

1.  Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity.

Authors:  A G MacDonald; G Birkinshaw; B Durham; R C Bucknall; W D Fraser
Journal:  Br J Rheumatol       Date:  1997-01

2.  Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.

Authors:  C-H Chen; K-C Lin; D T Y Yu; C Yang; F Huang; H-A Chen; T-H Liang; H-T Liao; C-Y Tsai; J C C Wei; C-T Chou
Journal:  Rheumatology (Oxford)       Date:  2005-11-15       Impact factor: 7.580

3.  Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis.

Authors:  U Lange; J Teichmann; H Stracke
Journal:  Eur J Med Res       Date:  2000-12-29       Impact factor: 2.175

4.  The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; N Akkoc; J Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; E Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

5.  Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis.

Authors:  H Yamanaka; Y Matsuda; M Tanaka; W Sendo; H Nakajima; A Taniguchi; N Kamatani
Journal:  Arthritis Rheum       Date:  2000-04

6.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

Authors:  K MacKay; C Mack; S Brophy; A Calin
Journal:  Arthritis Rheum       Date:  1998-12

9.  The effect of three years of TNFα blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study.

Authors:  Suzanne Arends; Anneke Spoorenberg; Pieternella M Houtman; Martha K Leijsma; Reinhard Bos; Cees Gm Kallenberg; Henk Groen; Elisabeth Brouwer; Eveline van der Veer
Journal:  Arthritis Res Ther       Date:  2012-04-30       Impact factor: 5.156

10.  Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.

Authors:  S Visvanathan; C Wagner; J C Marini; D Baker; T Gathany; J Han; D van der Heijde; J Braun
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

View more
  10 in total

1.  Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.

Authors:  Dongyi He; Qi Zhu; Quan Zhou; Qing Qi; Hongmei Sun; Liza M Zachariah; Grace Wang; John D Reveille; Yongtao Guan; Xiaodong Zhou
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

2.  A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology.

Authors:  Rowan Pentz; M Florencia Iulita; Maya Mikutra-Cencora; Adriana Ducatenzeiler; David A Bennett; A Claudio Cuello
Journal:  Neurobiol Dis       Date:  2020-10-30       Impact factor: 5.996

3.  Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity.

Authors:  Iria V Seoane; Eva Tomero; Carmen Martínez; Rosario Garcia-Vicuña; Yasmina Juarranz; Amalia Lamana; Elena Ocón; Ana M Ortiz; Nieves Gómez-León; Isidoro González-Álvaro; Rosa P Gomariz
Journal:  J Mol Neurosci       Date:  2015-02-25       Impact factor: 3.444

Review 4.  Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.

Authors:  Stefania Moz; Ada Aita; Daniela Basso; Roberta Ramonda; Mario Plebani; Leonardo Punzi
Journal:  Int J Mol Sci       Date:  2017-04-14       Impact factor: 5.923

5.  MicroRNA-146a suppresses rheumatoid arthritis fibroblast-like synoviocytes proliferation and inflammatory responses by inhibiting the TLR4/NF-kB signaling.

Authors:  Wei Liu; Yuan-Hao Wu; Lei Zhang; Bin Xue; Yi Wang; Bin Liu; Xiao-Ya Liu; Fang Zuo; Xiao-Yan Yang; Fu-Yu Chen; Ran Duan; Yue Cai; Bo Zhang; Yang Ji
Journal:  Oncotarget       Date:  2018-01-08

6.  Intensity of spinal inflammation is associated with radiological structural damage in patients with active axial spondyloarthritis.

Authors:  Jin Xian Huang; Ho Yin Chung; Eva Tze Fung Chui; Kam Ho Lee; Shirley Chiu Wai Chan; Helen Hoi Lun Tsang; Alexandra Hoi Yan Ng
Journal:  Rheumatol Adv Pract       Date:  2019-12-18

7.  Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis.

Authors:  María Lourdes Ladehesa-Pineda; Iván Arias de la Rosa; Clementina López Medina; María Del Carmen Castro-Villegas; María Del Carmen Ábalos-Aguilera; Rafaela Ortega-Castro; Ignacio Gómez-García; Pedro Seguí-Azpilcueta; Yolanda Jiménez-Gómez; Alejandro Escudero-Contreras; Chary López Pedrera; Nuria Barbarroja; Eduardo Collantes-Estévez
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-30       Impact factor: 5.346

8.  Severe bone marrow edema on sacroiliac joint MRI increases the risk of low BMD in patients with axial spondyloarthritis.

Authors:  Ha Neul Kim; Joon-Yong Jung; Yeon Sik Hong; Sung-Hwan Park; Kwi Young Kang
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

9.  IL-23R and IL-17A polymorphisms correlate with susceptibility of ankylosing spondylitis in a Southwest Chinese population.

Authors:  Bin Yang; Yuanwei Xu; Xinle Liu; Zhuochun Huang; Lanlan Wang
Journal:  Oncotarget       Date:  2017-08-18

10.  The relationship of ischemia-modified albumin levels to disease activity scores and HLA-B27 in patients with ankylosing spondylitis.

Authors:  Filiz Meryem Sertpoyraz; Ayfer Colak; Aylin Dikici; Nihan Erdinc Gunduz; Merve Zeytinli Aksit
Journal:  North Clin Istanb       Date:  2020-11-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.